SBRI RI Hea Healthcare lthcare Age genda nda Andy Burroughs - - PowerPoint PPT Presentation

sbri ri hea healthcare lthcare age genda nda
SMART_READER_LITE
LIVE PREVIEW

SBRI RI Hea Healthcare lthcare Age genda nda Andy Burroughs - - PowerPoint PPT Presentation

SBRI RI Hea Healthcare lthcare Age genda nda Andy Burroughs ughs, Wessex AHSN (Chair) - Welcome and introduction to AHSNs 14.00 Ka Karen Livings ngstone one National Director SBRI Healthcare - How SBRI works & what it has


slide-1
SLIDE 1

SBRI RI Hea Healthcare lthcare

slide-2
SLIDE 2

sbrihealthcare.co.uk

Age genda nda

14.00

Andy Burroughs ughs, Wessex AHSN (Chair) - Welcome and introduction to AHSNs Ka Karen Livings ngstone

  • ne – National Director SBRI Healthcare - How SBRI works & what it has delivered?

14.20

Stuart t Monk, Director of Innovation South West AHSN - Introduction to the Autumn 2017 calls

14.30

A focus on Mental Health: Jane Rowland, nd, He Head of Plannin ing g & Busin iness ess Developme elopment nt, , Avon & Wiltshi tshire re Menta tal He Health h Pa Partner ership ship Trust

15.00

A focus on surgery: Profess ssor

  • r Rober

ert t Hinchlif iffe, Profess ssor

  • r of Vascul

cular Surgery, Bristol

  • l Cent

ntre e for Surgical cal Resea earch, ch, Un Univer ersity sity of Bristol

  • l.

. 15.30

Ka Karen Livings ngstone

  • ne How to make a successful SBRI application

15.50 Q&A Networking 16.30 Close

slide-3
SLIDE 3

SBRI RI Hea Healthcare lthcare

Andy Burroughs, Director Wessex AHSN

slide-4
SLIDE 4

Welc lcome

  • me from

m th the e AHSN N Net Network

slide-5
SLIDE 5

What at do AHSNs Ns do?

Focus cus on the e needs eeds of patien ents s and local al popula ulati tion

  • ns:

s: sup uppor

  • rt

t and work k in partne nersh ship ip with th comm mmiss ssione ioners s and pub ublic c healt lth h bodies

  • dies to identify

entify and d addre ress ss un unme met healt lth h and d social ial care e need eds, s, whilst ilst promo moti ting ng health th equa uality ty and best st practice ice Speed eed up up adopti tion

  • n of inno

novat ation ion into

  • practice

tice to imp mprove e clinica ical out utcom comes es and patient ent exper perien ience ce – sup uppor

  • rt

t the e identif entifica cati tion

  • n and more

re rapid d up uptake e and spread ad of resea search ch eviden dence ce and inno novat ation ion at pace e and scale le to imp mprove e patient ent care e and local popul ulati tion

  • n healt

lth. h. Bui uild d a cul ulture ure of partner tnersh ship and colla labora borati tion:

  • n: promo
  • mote inclusivit

sivity, , partne nersh ship ip and d collabo aborat ation ion to consider nsider and addres ress s local, l, regional ional and national ional prior

  • rit

ities ies Creat ate e wealt lth h throu

  • ugh

gh co-de devel elopmen

  • pment,

t, testin ting, g, evaluat uation ion and d early y adopt ption ion and spread ead of new w produ

  • ducts

cts and servi vices ces Focus cus on the e needs eeds of patien ents s and local al popula ulati tion

  • ns:

s: sup uppor

  • rt

t and work k in partne nersh ship p with h commis mmissi sion

  • ners

s and pub ublic c health th bodies dies to identi entify fy and addres dress s un unme met t health alth and so social ial care e need eds, , whilst ilst promo moti ting ng health th equa ualit ity y and best practice ice Speed eed up up adopti tion

  • n of inno

novat ation ion into

  • practice

tice to imp mprove e clinica ical out utcom comes es and d patient ent exper perien ience ce – sup uppor

  • rt

t the e identif entifica cati tion

  • n and more

re rapid d up uptake e and spread ead of resear search ch evide denc nce and innovati tion

  • n at pace and

d scale e to imp mprove e patien ent t care e and local al popul ulati tion

  • n

healt lth. h. Bui uild d a cul ulture ure of partner tnersh ship and colla labora borati tion:

  • n: promo
  • mote inclusivit

sivity, , partne nersh ship p and collabo abora rati tion

  • n to consider

nsider and d addres ress s local, l, region ional and nation ional priori riti ties es Creat ate e wealt lth h throu

  • ugh

gh co-de devel elopmen

  • pment,

t, testin ting, g, evaluat uation ion and d early y adopt ption ion and d spread ead of new w produ

  • ducts

cts and servi vices ces

slide-6
SLIDE 6

What have we achie ieved?

slide-7
SLIDE 7

AHSN Obje jectives 2018 - 2023

slide-8
SLIDE 8

SBRI RI Hea Healthcare lthcare

Karen Livingstone, National Director SBRI Healthcare

slide-9
SLIDE 9

Helping the Public Sector address challenges

  • Using innovation to achieve a step change

Accelerating technology commercialisation

  • Providing a route to market

Support and the development of Innovative companies

  • Providing a lead customer/R&D partner
  • Providing funding and credibility for fund raising

SBRI is a pan-government, structured process enabling the Public Sector to engage with innovative suppliers:

SBRI RI Key y features eatures

slide-10
SLIDE 10

SBRI RI Key y features eatures

 100% funded R&D  Operate under procurement rules rather than state aid rules  UK implementation of EU Pre-Commercial Procurement  Deliverable based rather than hours worked or costs incurred

  • Contract with Prime Supplier

 Who may choose to sub contract but remains accountable

  • IP rests with Supplier

 Certain usage rights with Public Sector – Companies encouraged to exploit IP

  • Light touch Reporting & payments quarterly & up front
slide-11
SLIDE 11

Things to Note

  • Any size of business is eligible
  • Other organisations are eligible as long as the route to market is

demonstrated

  • All contract values quoted INCL

CLUD UDE VAT

  • Applications assessed on Fair Market Value
  • Contract terms are non-negotiable
  • Single applicant (partners shown as sub contractors)
  • Applicants must fully complete the application form
slide-12
SLIDE 12
  • Labour costs broken down by individual
  • Material Costs (inc consumables specific to the project)
  • Capital Equipment Costs
  • Sub-contract costs
  • Travel and subsistence
  • Other costs specifically attributed to the project
  • Indirect Costs:
  • General office and basic laboratory consumables
  • Library services/learning resources
  • Typing/secretarial
  • Finance, personnel, public relations and departmental services
  • Central and distributed computing
  • Cost of capital employed
  • Overheads

Eligible costs (all to include VAT)

slide-13
SLIDE 13

www.innovateuk.org/sbri

website contains details of all SBRI competitions

slide-14
SLIDE 14

SBRI RI Hea Healthcare lthcare

Launch Autumn Competition 2017 Mental Health Surgery

slide-15
SLIDE 15

SBRI Process

Problem Identification Open call to Industry Feasibility Testing Prototype development Pathway testing & Proof of Value

AHSN led - typically undertaken by clinicians – service driven AHSN led - Workshops with industry to support understanding PHASE 1: Typically 6 months – max of £100k PHASE 2: Typically 12 months – milestones agreed & monitored Due diligence & contracts PHASE 3: Typically 12 months – milestones agreed & monitored

Assessment

slide-16
SLIDE 16

New Competition October 2017

Competition launch: 18th October 2017 18 Closing Date: Noon 29th November Briefing Events: Bristol 24th October Nottingham 31st October Liverpool 3rd November r Assessments: December/January 2017/18 Interview panels: January 2018 Contracts awarded: March 2018

slide-17
SLIDE 17

sbrihealthcare.co.uk

How w do

  • we

e add dd value? ue?

slide-18
SLIDE 18

sbrihealthcare.co.uk

Be Benef efit it for

  • r pa

patient tients

  • 704k patients impacted to date
  • Potential to impact 59.5m
  • Reduced harm evidenced.
  • Reduced length of stay and no. of

GP appointments

  • Improved PROMs reporting – from

<2% to >40%

“I’m no longer worried about losing my driving licence, no longer worried about losing my house or my job. My last eye check up at the hospital confirmed that for the first time in over two years, BOTH my retinas are stable once again…with no signs of any small bleeds at all” (Polyphotnix patient)

slide-19
SLIDE 19

sbrihealthcare.co.uk

Be Benef efit it for

  • r th

the e NH NHS and nd wi wider der he health alth sy syst stem em

  • £17.8m cash releasing savings secured to the NHS

and social care to date

  • Estimated cumulative future savings to the NHS

expected to be of the order of £300- £440m in five years (2022), rising to between £1,100m - £1,800m in 10 years

  • 135 IP applications: Five NICE approvals submitted
  • 778 different NHS/care settings involved to date
slide-20
SLIDE 20

sbrihealthcare.co.uk

Be Benef efit it for

  • r bu

busi siness ness and nd th the ec e econ

  • nom
  • my
  • £140m private investment secured by SBRI

Healthcare backed companies

  • 788 jobs created or safeguarded with £47m

economic impact

  • 50 products on the market and available to

purchase – 18 companies are exporting & 3 have secured sales in excess of £500k

  • Companies have been created and have only

survived as a consequence of SBRI funding

slide-21
SLIDE 21

sbrihealthcare.co.uk

AHSN/ N/SBRI BRI co companies panies

Yorks & Humber Halliday James Ltd East Midlands Monica Healthcare Ltd, Astrimmune Ltd Eastern - Aseptika, Bespak, TwistDX S.London, Imperial, UCLP ABMS, Therakind, uMotif Wessex CreoMedical, Morgan Automation North East & North Cumbria Polyphotonix Ltd Kent, Surrey & Sussex Anaxsys, InMezzo NW Coast Veraz, Cardiocity West Midlands SensST Systems, Just Checking Ltd West of England SentiProfiling, My mHealth, HandAxe CIC South West Frazer Nash Oxford - Fuel 3D, Oxford Biosignals, Message Dynamics Scotland & N Ireland Radisens, Edixomed, Greater Manchester

  • Sky Med, & Rapid

Rhythm

slide-22
SLIDE 22

SBRI RI Hea Healthcare lthcare

Launch Autumn Competition 2017 Stuart Monk, Director of Innovation, South West AHSN

slide-23
SLIDE 23

Men ental tal Hea ealth lth

  • The Five Year Forward View for Mental Health reports that mental

health problems account for 25% of all ill health in the UK

  • One in four adults will experience mental health problems each year
  • Mental illness is the UK’s single largest cause of disability.
  • Mental health problems have an estimated economic and social cost
  • f £105 billion a year – approximately the cost of the entire NHS.
  • Nearly 1/3 of all people with a long-term physical health condition

also have a mental health problem, typically depression or anxiety

  • The effect of poor mental health on physical illnesses has been

estimated to cost the NHS at least £8 billion a year.

slide-24
SLIDE 24

Men ental tal Hea ealth lth Them emes es

  • Children and Young Peoples’

Mental Health

  • Suicide/Depression
  • Operational Productivity and New

Models of Care

slide-25
SLIDE 25

Tech echnolog nology y in Sur urger gery

  • Increasing pressure on the cost of delivering surgery and patient waiting times.
  • In the last 10 years, the number of surgical admissions to secondary care

increased by 27%, from 3.7 million in 2003/04 to 4.7 million in 2013/14 .

  • There are over three thousand NHS operating theatres in England
  • 19% of which are dedicated day case theatres
  • Annual expenditure on surgery in the NHS has been estimated at £4.5 billion

(2013).

  • The 92% target for all patients to be seen within 18 weeks has not been met since

February 2016.

  • NHS Improvement today! Believes operating theatres could be saving 2 hours a

today through increased efficiency

slide-26
SLIDE 26

Tech echnolog nology y in Sur urger gery y The heme mes

  • Technologies to assist with surgical

procedures

  • Preoperative surgical simulation

technologies

slide-27
SLIDE 27

SBRI RI He Healthcare lthcare

Jane Rowland, Head of Planning and Business Development, Avon and Wiltshire Mental Health Partnership NHS Trust A focus on Mental Health

slide-28
SLIDE 28

Mental Health

24th October 2016

Jane Rowland - Head of Planning and Development

slide-29
SLIDE 29

Mental health today

slide-30
SLIDE 30

Change is happening..

  • CAMHS – Better access to local services

for children and young people, including specialist provision

  • Perinatal mental health – community

teams to support more women, close to home

  • Adult mental health – improve access to

lower level mental health services and crisis response when needed

  • Secure care – enable more people to be

treated closer to home

  • Health and Justice – improvements in

Liaison and Diversion

  • Suicide Prevention – reducing the

number of suicides by 10%

  • New care models – for specialist

services, including Eating Disorders, CAMHS and Secure Care

slide-31
SLIDE 31

The ask for mental health…

slide-32
SLIDE 32

Using technology differently

  • An increasingly ‘tech savvy’ population

but….a health system that doesn’t make best use of it

  • Engaging service users – at every age and

stage

  • Making use of the technology we have

available to us

  • Joining up with other providers and

commissioners

  • Using big data to track patterns and changes

we need to make

slide-33
SLIDE 33

Mental health services

slide-34
SLIDE 34

NHS England commissioned services

Eating Disorders: 10 bedded unit located in Bristol, adjacent to Southmead Hospital CAMHS: 9 bedded unit, on the Blackberry Hill site in Bristol Secure: 112 bedded unit – both medium and low secure at Fromeside Hospital, Blackberry Hill Perinatal: 4 bedded Mother and Baby Unit, adjacent to Southmead Hospital Other units across the south west

slide-35
SLIDE 35

Challenge for service users

  • Relatively, south west has fewer specialist

beds than rest of England

  • When beds are not available, service users

have to travel out of area for treatment

  • NHS England track all service users

through the Specialist Mental Health database (SMH)

  • Service users are repatriated back to in

area beds when possible

slide-36
SLIDE 36

The importance of data

  • We need data to:

– Understand our service users – Know where service users are in their treatment pathway – Case manage their care

  • What we don’t have is:

– A joined up system – Shared oversight of all service users

  • What this leads to:

– Lots of manual data entry and validation – Potential for inaccuracy/omission

slide-37
SLIDE 37

What we need

  • A solution that sits between RiO (the Trust
  • perating system) and the SMH Database
  • Integrity of information – without lots of data

checking and analysis

  • Case managers who are able to concentrate
  • n clinical pathways, not reconciliation

But…..

  • Integration engines are expensive to design

and implement

  • Management of any system has to be simple
slide-38
SLIDE 38

SBRI RI He Healthcare lthcare

Prof Robert Hinchliffe, Professor of Vascular Surgery, Bristol Centre for Surgical Research, University of Bristol A focus on Surgery

slide-39
SLIDE 39

Clinical Presentation – Technology in Surgery

Professor Robert Hinchliffe Professor of Vascular Surgery University of Bristol & Bristol, Bath & Weston Vascular Network

slide-40
SLIDE 40

Overview

  • Innovations
  • Desirables
  • Current climate
  • Evaluating new technology and procedures

40

slide-41
SLIDE 41

Innovations in vascular surgery

41

Balloon angioplasty Embolectomy balloon catheters Stents Branch stent-grafts Stent-grafts Endovenous ablation Prosthetic grafts

slide-42
SLIDE 42

What I (any surgeon) would like

  • Augment my senses
  • Understand where I am + help to get somewhere else
  • Familiar environment (standard operating theatre)
  • Improve outcomes (standardise)
  • Limited resources (standard kit)

42

slide-43
SLIDE 43

Please – no more ‘robots’

43

slide-44
SLIDE 44

Surgery – pre-operative planning

  • Anticipate problems
  • Management strategy
  • Alternative solutions

44

slide-45
SLIDE 45

45

Technologies to assist the surgical procedure

slide-46
SLIDE 46

46

Cydar Medical

slide-47
SLIDE 47

Innovation, evolution & adoption poorly regulated & reported

slide-48
SLIDE 48

Phases 0-1: Pharmacodynamics & safety screening Phases 2-3: Testing & full evaluation

slide-49
SLIDE 49

49

Phase 4: Post approval surveillance

slide-50
SLIDE 50

50

slide-51
SLIDE 51

51

slide-52
SLIDE 52

Surgical innovation

52

slide-53
SLIDE 53

53

slide-54
SLIDE 54

54

slide-55
SLIDE 55

NHS patients are missing out on life-saving robot surgery

(Guardian 13th April 2014)

55

“New treatments are being introduced in a haphazard fashion, says surgeon's body (Royal College of Surgeons)”

slide-56
SLIDE 56

Evaluation of innovation: Safe, efficient & transparent

slide-57
SLIDE 57

Design & optimise interventions & co-interventions

slide-58
SLIDE 58

NIHR Bristol Biomedical Research Centre

58

http://www.uhbristol.nhs.uk/research-innovation/our-research/nihrbristolbrc/

slide-59
SLIDE 59

Bristol Centre for Surgical Research

Surgical Innovation Theme

59

slide-60
SLIDE 60

Aim: to transform early phase study design

  • New methods for safe & transparent translation
  • f innovation
  • Expedition of rejection of ineffective techniques
  • Efficient trial design

Ultimately inform evidence-based surgical practice

60

slide-61
SLIDE 61

Evaluation of innovation

Early phase design & intervention definition Information provision & informed consent Selection, measurement & reporting

  • utcomes

Design interventions and co-interventions

Identify active (clusters) of interventions/co-interventions using network meta-analyses Utilise surgical registries to identify

  • utliers, innovators and successful

interventions Develop novel co-interventions using mixed methods

Overview of the theme

slide-62
SLIDE 62

Core Outcome Measures in Effectiveness Trials http://www.comet-initiative.org/home/

@COMETinitiative

slide-63
SLIDE 63

‘Clinical trials are only as credible as their

  • utcomes’ Tugwell 1993
slide-64
SLIDE 64

“…a method of gauging the effectiveness of an intervention” Why are outcomes important?

slide-65
SLIDE 65

“You need to know about customer feedback that says things should be better.” Bill Gates

Patient reported outcomes also important

slide-66
SLIDE 66

.... and information used in practice to inform decision-making

slide-67
SLIDE 67

Heterogeneity of outcomes Outcomes definition & measurement Outcome reporting bias Problems with outcomes

slide-68
SLIDE 68

Methods

Identify potential outcomes Consensus meeting (s) Comprehensive outcome list Create a questionnaire survey Delphi surveys Core outcome set Identify key stakeholders

slide-69
SLIDE 69

Oesophageal surgery for cancer

‘Long list’ of all possible outcomes

Literature of patient- reported outcomes Consultations & patient interviews National Audit Data 2010 (AUGIS) Review of patient information leaflets Literature review of clinical outcomes n=248

slide-70
SLIDE 70
slide-71
SLIDE 71

Listed them all verbatim

Activities of daily living Activity level Anger-Hostility Anxiety Appetite loss Bloating Bodily pain Body image Bowel & bladder function Bowel habits Breathing Choking Cognitive function Confusion-Bewilderment Constipation Cough Deglutition Deglutition disturbances Depression Depression-Dejection Diarrhoea Diarrhoea/Constipation Difficulty in swallowing Domestic environment Dry mouth Dumping Dysphagia Dyspnoea Eating Eating & drinking Eating restrictions Eating with others Emotion Emotional function Emotional problems (anxiety) Emotional well-being Employment status & finances Energy Esophageal cancer scale Extended family relationships Fatigue

General Health Global Evaluations Global QOL Global Satisfaction Global life satisfaction Hair loss Health perceptions Healthcare Orientation Heartburn Height Hoarseness Indigestion Information needs Insomnia Knowledge / communication Location of dysphagia Loss of independence Loss of weight Meal and snack frequency Medical Treatment

slide-72
SLIDE 72

Oesophageal surgery for cancer

Long list N=701

Literature of patient- reported outcomes Consultations & patient interviews National Audit Data 2010 (AUGIS) Review of patient information leaflets Literature review of clinical outcomes

Outcome domains N=67

slide-73
SLIDE 73

Death In-hospital mortality Operative mortality Death (domain) Post-operative mortality Overall mortality 30-day mortality Mortality Intra-operative mortality

An example – outcomes to domain

slide-74
SLIDE 74

Death In-hospital mortality Operative mortality Death (domain) Post-operative mortality Overall mortality 30-day mortality Mortality Intra-operative mortality

E.g. Outcomes to domain to item

Dying in hospital after the operation

slide-75
SLIDE 75

SCHOOL OF SOCIAL AND COMMUNITY MEDICINE 07/02/14

Why are single items needed?

slide-76
SLIDE 76

Conclusions

  • Surgical innovation – augmentation (simple)
  • Heightened time of caution / fiscal control
  • Rigorous assessment
  • Bristol NIHR BRC – evaluation methodology
  • Standardised outcome measures in ALL new surgical technology

76

slide-77
SLIDE 77

77

slide-78
SLIDE 78

SBRI RI Hea Healthcare lthcare

Karen Livingstone, National Director SBRI Healthcare

slide-79
SLIDE 79

SBRI Healthcare sbrienquiries@hee.co.uk 01223 928040 www.sbrihealthcare.co.uk @sbrihealthcare

The application process

slide-80
SLIDE 80

sbrihealthcare.co.uk

App pplicat lication ion Process

  • cess

www.sbrih sbrihea ealth lthca care re.c .co.uk

  • .uk
slide-81
SLIDE 81

sbrihealthcare.co.uk

slide-82
SLIDE 82

sbrihealthcare.co.uk

App pplicat lication ion Process

  • cess
slide-83
SLIDE 83

sbrihealthcare.co.uk

slide-84
SLIDE 84

sbrihealthcare.co.uk

Ass ssess essment ment Pha hase se Timelines melines

  • Close competition, noon on 6th September
  • Review compliance (Early September)
  • Assessment packs assigned and issued to Technical Assessors

(Early September)

  • Each application reviewed & scored by Technical (early

September)

  • Assessment of long-list applications at panel meeting involving

clinical leads (mid September)

  • Production of rank ordered list for interview (late September)
  • Interview panels to select final winners (October)
  • Draft and issue contracts (November)
  • Publish contracts awarded (November)
  • Feedback to unsuccessful applicants (throughout, but latest

November)

slide-85
SLIDE 85
  • 1. What will be the effect of this proposal on the challenge addressed?
  • 2. What is the degree of technical challenge? How innovative is the project?
  • 3. Will the technology have a competitive advantage over existing/alternate

technologies that can meet the market needs?

  • 4. Are the milestones and project plan appropriate?
  • 5. Is the proposed development plan a sound approach?
  • 6. Does the proposed project have an appropriate commercialisation plan and does

the size of the market justify the investment?

  • 7. Does the company appear to have the right skills and experience to deliver the

intended benefits?

  • 8. Does the proposal look sensible financially? Is the overall budget realistic and

justified in terms of the aims and methods proposed?

Assessment Cri riteria

slide-86
SLIDE 86

Key P y Poi

  • ints

nts to R

  • Rem

ememb ember er

  • Research and define the market/patient need
  • Review the direct competitor landscape and make sure you define your USP
  • Consider your route to market, what is the commercialisation plan? Do you know who

your customer will be, how will you distribute, how much will you charge for the product/service?

  • How will the project be managed (what tools will you use, how will the team

communicate etc)

  • Provide a clear cost breakdown
  • Make sure you answer all of the questions in sufficient detail
  • Try not to use too much technical jargon, sell the project in terms the NHS will

understand (outcomes, benefits to patients etc)

slide-87
SLIDE 87

Health Enterprise East - SBRI Healthcare Programme Management sbrienquiries@hee.co.uk

www.sbrihealthcare.co.uk @sbrihealthcare

Contact Us

slide-88
SLIDE 88

Karen Livingstone SBRI Healthcare National Director karen.livingstone@eahsn.org 01223 257271 Joop Tanis

Director SBRI Healthcare Programme

sbrienquiries@hee.co.uk 01223 928040 www.sbrihealthcare.co.uk @sbrihealthcare

Contact Us

slide-89
SLIDE 89

Kate Phillips WE AHSN kate.phillips@weahsn.net Andy Burroughs

Wessex AHSN

andy.burroughs@wessexahsn.net www.sbrihealthcare.co.uk @sbrihealthcare

For Application Support….

slide-90
SLIDE 90

SBRI RI Hea Healthcare lthcare

Any Questions?